Reduced in vitro T-cell responses induced by glutaraldehyde-modified allergen extracts are caused mainly by retarded internalization of dendritic cells

Immunology

Volumn 136, Issue 2, 2012, Pages 208-217

  Heydenreich, Bärbel ^a   Bellinghausen, Iris ^a   Lorenz, Steffen ^a   Henmar, Helene ^b   Strand, Dennis ^a   Würtzen, Peter A ^b   Saloga, Joachim ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ALK ABELLÓ   (Denmark)

Author keywords

Allergen; Allergoid; Basophils; Dendritic cells; T helper type 1 T helper type 2

Indexed keywords

ALLERGEN; GAMMA INTERFERON; GLUTARALDEHYDE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE; POLLEN EXTRACT;

ALLERGENICITY; ARTICLE; BASOPHIL; BETULA VERRUCOSA; BIRCH; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON PRODUCTION; INTERNALIZATION; LEUKOCYTE ACTIVATION; PHLEUM PRATENSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ALLERGENS; BASOPHILS; BETULA; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; EPITOPES; FORMALDEHYDE; GLUTARAL; HUMANS; LEUKOTRIENES; LYMPHOCYTE ACTIVATION; PHLEUM; PLANT EXTRACTS;

EID: 84860241112     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2012.03571.x     Document Type: Article

References (42)

1. Ricci M, Rossi O, Bertoni M, Matucci A. The importance of Th2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy 1993; 23:360-9.
2. Oettgen HC, Geha RS. IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 2001; 107:429-40.
3. H2-type immune responses initiated and amplified? Nat Rev Immunol 2010; 10:225-35.
4. Lambrecht BN. The dendritic cell in allergic airway diseases: a new player to the game. Clin Exp Allergy 2001; 31:206-18.
5. Calderon MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol 2011; 127:30-8.
6. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27:1131-9.
7. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
8. Bellinghausen I, König B, Böttcher I, Knop J, Saloga J. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-β for their induction. Clin Exp Allergy 2006; 36:1546-55.
9. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007; 119:780-91.
10. Van Neerven RJ, Knol EF, Ejrnaes A, Wurtzen PA. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy. Int Arch Allergy Immunol 2006; 141:119-29.
11. Marsh DG, Lichtenstein LM, Campbell DH. Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology 1970; 18:705-22.
12. Yang X, Gieni RS, Mosmann TR, HayGlass KT. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med 1993; 178:349-53.
13. von Baehr V, Hermes A, von Baehr R, Scherf HP, Volk HD, Fischer von Weikersthal-Drachenberg KJ, Woroniecki S. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine. J Investig Allergol Clin Immunol 2005; 15:234-41.
14. Ibarrola I, Sanz ML, Gamboa PM et al. Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts. Clin Exp Allergy 2004; 34:303-9.
15. Casanovas M, Fernandez-Caldas E, Alamar R, Basomba A. Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 2005; 137:211-18.
16. Dormann D, Ebner C, Jarman ER, Montermann E, Kraft D, Reske-Kunz AB. Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids). Clin Exp Allergy 1998; 28:1374-83.
17. + T cell responses to house dust mite allergoid. Allergy 2003; 58:648-56.
18. Lund L, Henmar H, Wurtzen PA, Lund G, Hjortskov N, Larsen JN. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy. Clin Exp Allergy 2007; 37:564-71.
19. Wurtzen PA, Lund L, Lund G, Holm J, Millner A, Henmar H. Chemical modification of birch allergen extract leads to a reduction in allergenicity as well as immunogenicity. Int Arch Allergy Immunol 2007; 144:287-95.
20. Kahlert H, Grage-Griebenow E, Stuwe HT, Cromwell O, Fiebig H. T cell reactivity with allergoids: influence of the type of APC. J Immunol 2000; 165:1807-15.
21. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
22. Lee TM, Grammer LC, Shaughnessy MA, Patterson R. Modified antigens in the treatment of allergic disease. Year Immunol 1986; 2:338-50.
23. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27:3135-42.
24. Kaliński P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997; 159:28-35.
25. Haavik S, Smestad Paulsen B, Wold JK. Glycoprotein allergens in pollen of timothy. I. Investigation of carbohydrates extracted from pollen of timothy (Phleum pratense) and purification of a carbohydrate-containing allergen by affinity chromatography on concanavalin A-Sepharose. Int Arch Allergy Appl Immunol. 1985; 78:197-205.
26. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products [see comments]. J Exp Med 1995; 182:389-400.
27. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007; 316:612-16.
28. Kahlert H, Stuwe H, Cromwell O, Fiebig H. Reactivity of T cells with grass pollen allergen extract and allergoid. Int Arch Allergy Immunol 1999; 120:146-57.
29. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J Immunol 1995; 154:6285-90.
30. Noirey N, Rougier N, Andre C, Schmitt D, Vincent C. Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. J Allergy Clin Immunol 2000; 105:1194-201.
31. Maurer D, Fiebiger S, Ebner C et al. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα- and FcεRI γ-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996; 157:607-16.
32. Henmar H, Lund G, Lund L, Petersen A, Wurtzen PA. Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy. Clin Exp Immunol 2008; 153:316-23.
33. Bellinghausen I, Häringer B, Lafargue B, Strand D, Konig B, Decker H, Saloga J. Allergological implication of the quaternary hexameric structure of the cockroach allergen Per a 3. Clin Exp Allergy 2008; 38:539-48.
34. Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000; 55:1142-7.
35. Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005; 60:801-7.
36. Ceuppens JL, Bullens D, Kleinjans H, van der WJ. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects. Clin Exp Allergy 2009; 39:1903-9.
37. Rosewich M, Schulze J, Eickmeier O, Telles T, Rose MA, Schubert R, Zielen S. Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children. Clin Exp Immunol 2010; 160:403-10.
38. Riechelmann H, Schmutzhard J, van der Werf JF, Distler A, Kleinjans HA. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis. Am J Rhinol Allergy 2010; 24:e104-9.
39. Zielen S, Kardos P, Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol 2010; 126:942-9.
40. Cosmi L, Santarlasci V, Angeli R et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10-production. Clin Exp Allergy 2006; 36:261-72.
41. Burastero SE, Mistrello G, Falagiani P et al. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production. Ann Allergy Asthma Immunol 2008; 100:343-50.
42. James LK, Durham SR. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy 2008; 38:1074-88.